chr22-33283252-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_133642.5(LARGE1):​c.1827A>G​(p.Ser609Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00976 in 1,614,120 control chromosomes in the GnomAD database, including 386 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.022 ( 90 hom., cov: 32)
Exomes 𝑓: 0.0085 ( 296 hom. )

Consequence

LARGE1
NM_133642.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.84

Publications

2 publications found
Variant links:
Genes affected
LARGE1 (HGNC:6511): (LARGE xylosyl- and glucuronyltransferase 1) This gene encodes a member of the N-acetylglucosaminyltransferase gene family. It encodes a glycosyltransferase which participates in glycosylation of alpha-dystroglycan, and may carry out the synthesis of glycoprotein and glycosphingolipid sugar chains. It may also be involved in the addition of a repeated disaccharide unit. The protein encoded by this gene is the glycotransferase that adds the final xylose and glucuronic acid to alpha-dystroglycan and thereby allows alpha-dystroglycan to bind ligands including laminin 211 and neurexin. Mutations in this gene cause several forms of congenital muscular dystrophy characterized by cognitive disability and abnormal glycosylation of alpha-dystroglycan. Alternative splicing of this gene results in multiple transcript variants that encode the same protein. [provided by RefSeq, May 2018]
LARGE1 Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy-dystroglycanopathy type B6
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • congenital muscular dystrophy with intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 22-33283252-T-C is Benign according to our data. Variant chr22-33283252-T-C is described in ClinVar as Benign. ClinVar VariationId is 95169.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.84 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0562 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_133642.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LARGE1
NM_133642.5
MANE Select
c.1827A>Gp.Ser609Ser
synonymous
Exon 13 of 15NP_598397.1O95461-1
LARGE1
NM_001362949.2
c.1827A>Gp.Ser609Ser
synonymous
Exon 14 of 16NP_001349878.1O95461-1
LARGE1
NM_001362951.2
c.1827A>Gp.Ser609Ser
synonymous
Exon 13 of 15NP_001349880.1O95461-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LARGE1
ENST00000397394.8
TSL:5 MANE Select
c.1827A>Gp.Ser609Ser
synonymous
Exon 13 of 15ENSP00000380549.2O95461-1
LARGE1
ENST00000354992.7
TSL:1
c.1827A>Gp.Ser609Ser
synonymous
Exon 14 of 16ENSP00000347088.2O95461-1
LARGE1
ENST00000402320.6
TSL:1
c.1671A>Gp.Ser557Ser
synonymous
Exon 12 of 14ENSP00000385223.1O95461-2

Frequencies

GnomAD3 genomes
AF:
0.0223
AC:
3393
AN:
152116
Hom.:
89
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0581
Gnomad AMI
AF:
0.0241
Gnomad AMR
AF:
0.0160
Gnomad ASJ
AF:
0.0320
Gnomad EAS
AF:
0.00309
Gnomad SAS
AF:
0.0545
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.00370
Gnomad OTH
AF:
0.0278
GnomAD2 exomes
AF:
0.0159
AC:
3992
AN:
251418
AF XY:
0.0173
show subpopulations
Gnomad AFR exome
AF:
0.0603
Gnomad AMR exome
AF:
0.00789
Gnomad ASJ exome
AF:
0.0296
Gnomad EAS exome
AF:
0.00283
Gnomad FIN exome
AF:
0.000554
Gnomad NFE exome
AF:
0.00441
Gnomad OTH exome
AF:
0.0122
GnomAD4 exome
AF:
0.00845
AC:
12357
AN:
1461886
Hom.:
296
Cov.:
32
AF XY:
0.00999
AC XY:
7263
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.0637
AC:
2131
AN:
33476
American (AMR)
AF:
0.00923
AC:
413
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0288
AC:
752
AN:
26136
East Asian (EAS)
AF:
0.00159
AC:
63
AN:
39700
South Asian (SAS)
AF:
0.0578
AC:
4982
AN:
86258
European-Finnish (FIN)
AF:
0.000599
AC:
32
AN:
53420
Middle Eastern (MID)
AF:
0.0383
AC:
221
AN:
5768
European-Non Finnish (NFE)
AF:
0.00257
AC:
2861
AN:
1112008
Other (OTH)
AF:
0.0149
AC:
902
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
816
1632
2447
3263
4079
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0223
AC:
3399
AN:
152234
Hom.:
90
Cov.:
32
AF XY:
0.0231
AC XY:
1719
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.0581
AC:
2416
AN:
41548
American (AMR)
AF:
0.0160
AC:
245
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0320
AC:
111
AN:
3470
East Asian (EAS)
AF:
0.00290
AC:
15
AN:
5164
South Asian (SAS)
AF:
0.0545
AC:
263
AN:
4822
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10608
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.00372
AC:
253
AN:
68014
Other (OTH)
AF:
0.0275
AC:
58
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
164
329
493
658
822
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0131
Hom.:
28
Bravo
AF:
0.0252
Asia WGS
AF:
0.0310
AC:
106
AN:
3478
EpiCase
AF:
0.00583
EpiControl
AF:
0.00634

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
2
Muscular dystrophy-dystroglycanopathy type B6 (2)
-
-
1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.15
DANN
Benign
0.36
PhyloP100
-1.8
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11913417; hg19: chr22-33679238; API